207 related articles for article (PubMed ID: 19876652)
1. A case of minimal change disease in a Fabry patient.
Zarate YA; Patterson L; Yin H; Hopkin RJ
Pediatr Nephrol; 2010 Mar; 25(3):553-6. PubMed ID: 19876652
[TBL] [Abstract][Full Text] [Related]
2. Sudden onset of nephrotic syndrome in an asymptomatic Fabry patient: a case report.
Zhang R; Chen Z; Lang Y; Shao S; Cai Y; You Q; Sun Y; Wang S; Shi X; Liu Z; Guo W; Han Y; Shao L
Ren Fail; 2020 Nov; 42(1):958-965. PubMed ID: 32924720
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of immunosuppressive therapy for nephrotic syndrome in a patient with late-onset Fabry disease: a case report and literature review.
Fujisawa H; Nakayama Y; Nakao S; Yamamoto R; Kurokawa Y; Nakamura N; Nagata A; Tsukimura T; Togawa T; Sakuraba H; Fukami K
BMC Nephrol; 2019 Dec; 20(1):469. PubMed ID: 31847900
[TBL] [Abstract][Full Text] [Related]
4. Long-term enzyme replacement therapy is associated with reduced proteinuria and preserved proximal tubular function in women with Fabry disease.
Prabakaran T; Birn H; Bibby BM; Regeniter A; Sørensen SS; Feldt-Rasmussen U; Nielsen R; Christensen EI
Nephrol Dial Transplant; 2014 Mar; 29(3):619-25. PubMed ID: 24215016
[TBL] [Abstract][Full Text] [Related]
5. Podocyturia is significantly elevated in untreated vs treated Fabry adult patients.
Trimarchi H; Canzonieri R; Schiel A; Politei J; Stern A; Andrews J; Paulero M; Rengel T; Aráoz A; Forrester M; Lombi F; Pomeranz V; Iriarte R; Young P; Muryan A; Zotta E
J Nephrol; 2016 Dec; 29(6):791-797. PubMed ID: 26842625
[TBL] [Abstract][Full Text] [Related]
6. Fabry disease: renal involvement limited to podocyte pathology and proteinuria in a septuagenarian cardiac variant. Pathologic and therapeutic implications.
Meehan SM; Junsanto T; Rydel JJ; Desnick RJ
Am J Kidney Dis; 2004 Jan; 43(1):164-71. PubMed ID: 14712441
[TBL] [Abstract][Full Text] [Related]
7. Stroke and Chronic Kidney Disease in Fabry Disease.
Tapia D; Kimonis V
J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105423. PubMed ID: 33160817
[TBL] [Abstract][Full Text] [Related]
8. [Fabry nephropathy in a female with superposed IgA glomerulonephritis].
Pisani A; Sessa A; Sabbatini M; Andreucci MV; Fusco C; Balletta M; Cianciaruso B
G Ital Nefrol; 2005; 22(4):385-9. PubMed ID: 16267800
[TBL] [Abstract][Full Text] [Related]
9. Control of proteinuria with increased doses of agalsidase alfa in a patient with Fabry disease with atypical genotype-phenotype expression.
Paliouras C; Aperis G; Lamprianou F; Ntetskas G; Roufas K; Alivanis P
Nefrologia; 2015; 35(6):578-81. PubMed ID: 26384850
[TBL] [Abstract][Full Text] [Related]
10. The kidney in Fabry's disease.
Pisani A; Visciano B; Imbriaco M; Di Nuzzi A; Mancini A; Marchetiello C; Riccio E
Clin Genet; 2014 Oct; 86(4):301-9. PubMed ID: 24645664
[TBL] [Abstract][Full Text] [Related]
11. Foot process effacement is an early marker of nephropathy in young classic Fabry patients without albuminuria.
Tøndel C; Kanai T; Larsen KK; Ito S; Politei JM; Warnock DG; Svarstad E
Nephron; 2015; 129(1):16-21. PubMed ID: 25531941
[TBL] [Abstract][Full Text] [Related]
12. A case of Fabry nephropathy with histological features of oligonephropathy.
Nishida M; Kosaka K; Hasegawa K; Nishikawa K; Itoi T; Tsukimura T; Togawa T; Sakuraba H; Hamaoka K
Eur J Pediatr; 2014 Aug; 173(8):1111-4. PubMed ID: 23913314
[TBL] [Abstract][Full Text] [Related]
13. Long-term enzyme replacement therapy for Fabry disease: efficacy and unmet needs in cardiac and renal outcomes.
Kim JH; Lee BH; Hyang Cho J; Kang E; Choi JH; Kim GH; Yoo HW
J Hum Genet; 2016 Nov; 61(11):923-929. PubMed ID: 27334365
[TBL] [Abstract][Full Text] [Related]
14. First phenotypic description of a female patient with c.610 T > C variant of GLA: a renal-predominant presentation of Fabry disease.
Greillier S; Daniel L; Caillaud C; Dussol B; Touchard G; Goujon JM; Jourde-Chiche N; Bobot M
BMC Med Genet; 2020 Jun; 21(1):137. PubMed ID: 32590976
[TBL] [Abstract][Full Text] [Related]
15. Fabry disease--a diagnostic and therapeutic problem.
Strujić BJ; Jeren T
Ren Fail; 2005; 27(6):783-6. PubMed ID: 16350834
[TBL] [Abstract][Full Text] [Related]
16. Cardiac involvement in Fabry disease - A non-invasive assessment and the role of specific therapies.
Hongo K
Mol Genet Metab; 2022; 137(1-2):179-186. PubMed ID: 36088815
[TBL] [Abstract][Full Text] [Related]
17. Renal complications of Fabry disease in children.
Najafian B; Mauer M; Hopkin RJ; Svarstad E
Pediatr Nephrol; 2013 May; 28(5):679-87. PubMed ID: 22898981
[TBL] [Abstract][Full Text] [Related]
18. Enzyme Replacement Therapy Clears Gb3 Deposits from a Podocyte Cell Culture Model of Fabry Disease but Fails to Restore Altered Cellular Signaling.
Braun F; Blomberg L; Brodesser S; Liebau MC; Schermer B; Benzing T; Kurschat CE
Cell Physiol Biochem; 2019; 52(5):1139-1150. PubMed ID: 30990584
[TBL] [Abstract][Full Text] [Related]
19. Early renal failure in childhood in a male with Fabry disease.
Hogh JN; Ebrahim H; Moochhala S; Ramaswami U
BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35537774
[TBL] [Abstract][Full Text] [Related]
20. Nephrotic syndrome due to minimal-change disease superimposed on anti-glomerular basement membrane antibody positive glomerulonephritis; a case report.
Shibata Y; Fukuoka K; Yokota R; Lee H; Sayo H; Ikegaya N; Mori K; Yamamoto J; Isomura A; Nagahama K; Shimoyamada H; Kawakami T; Komagata Y; Kaname S
BMC Nephrol; 2020 Jul; 21(1):283. PubMed ID: 32680573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
